Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2730

NCT03054194 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: E2730
DRUG: Placebo

Sponsor

Eisai Inc.